Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Mostrar biografía de los autores
La miocarditis fetal es una entidad poco frecuente, por lo que es difícil conocer la real incidencia y prevalencia. Es el primer caso que observamos. Las causas pueden ser clasificadas como infecciosas o no infecciosas. En las primeras los agentes virales son los que más se asocian con esta entidad. Presentamos un caso autópsico de un óbito fetal de sexo masculino con 27 semanas de gestación de una madre de 24 años de edad con infección por parvovirus B19. En la autopsia clínica se observó ascitis, hepatoesplenomegalia y a nivel histopatológico severo infiltrado inflamatorio linfocitario intersticial y perivascular acompañado de necrosis, rotura de fibras musculares y edema.
Visitas del artículo 409 | Visitas PDF 170
Descargas
1. Gilbert-Barness E. Potter’s pathology of the fetus, infant and child. Philadelphia: Mosby Elsevier; 2007. p. 2444.
2. Fesslova V, Mongiovi M, Pipitone S, Brankovic J, Villa L. Features and outcomes in utero and after birth of fetuses with myocardial disease. Int J Pediatr. 2010;2010:628451.
3. Hichijo A, Morine M. A case of fetal parvovirus B19 myocarditis that caused terminal heart failure. Case Rep Obstet Gynecol. 2014;2014:463571.
4. Xu J, Raff TC, Muallem NS, Neubert AG. Hydrops fetalis secondary to parvovirus B19 infections. J Am Board Fam Pract. 2003;16:63–8.
5. von Kaisenberg CS, Grebe S, Schleider S, Kuhling-von Kaisenberg H, Venhoff L, Meinhold-Heerlein I. Successful intrauterine intracardiac transfusion in monochorionic twins affected by parvovirus B19. Fetal Diagn Ther. 2007;22:420–4.
6. Crane J, Mundle W, Boucoiran I, Gagnon R, Bujold E, Basso M, et al. Maternal fetal medicine. Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can. 2014;36:1107–16.
7. Tavora F, Gonzalez-Cuyar LF, Dalal JS, O’Malley MT, Zhao R, Peng HQ, et al. Fatal parvoviral myocarditis: A case report and review of literature. Diagn Pathol. 2008;3:21.
8. Chen CC, Chen CS, Wang WY, Ma JS, Shu HF, Fan FS. Parvovirus B19 infection presenting with severe erythroid aplastic crisis during pregnancy in a woman with autoimmune hemolytic anemia and alpha-thalassemia trait: A case report. J Med Case Rep. 2015;9:58.
9. Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease. BMJ. 1990;300(6733):1166–70.
10. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998;105:174–8.
11. Cohen B. Parvovirus B19: An expanding spectrum of disease. BMJ. 1995;311(7019):1549–52.
12. Giorgio E, de Oronzo MA, Iozza I, di Natale A, Cianci S, Garofalo G, et al. Parvovirus B19 during pregnancy: A review. J Prenat Med. 2010;4:63–6.
13. Dettmeyer R, Kandolf R, Baasner A, Banaschak S, Eis-Hubinger AM, Madea B. Fatal parvovirus B19 myocarditis in an 8-year-old boy. J Forensic Sci. 2003;48:183–6.
14. Murry CE, Jerome KR, Reichenbach DD. Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol. 2001;32:342–5.
15. Jordan JA, Huff D, DeLoia JA. Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immunol. 2001;8:288–92.
16. Koduri PR. Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infection. Am J Hematol. 1998;58:95–9.
17. Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B 19 during pregnancy: A review. Obstet Gynecol Surv. 1997;52:254–9.
18. Markenson GR, Yancey MK. Parvovirus B19 infections in pregnancy. Semin Perinatol. 1998;22:309–17.
19. Rodis JF. Parvovirus infection. Clin Obstet Gynecol. 1999;42:107–20.